AU Patent

AU2702795A — Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration

Assigned to Procter and Gamble Co · Expires 1996-01-19 · 30y expired

What this patent protects

Patent listed against Adasuve.

Drugs covered by this patent

Patent Metadata

Patent number
AU2702795A
Jurisdiction
AU
Classification
—
Expires
1996-01-19
Drug substance claim
No
Drug product claim
No
Assignee
Procter and Gamble Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.